These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 423209)

  • 21. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synthesis and some pharmacological activities of [2-L-valine]-oxytocin and [2-L-leucine]-oxytocin.
    Hruby VJ; Du Vigneaud V
    J Med Chem; 1969 Sep; 12(5):731-3. PubMed ID: 5818088
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
    Smith CW; Botos CR; Skala G; Walter R
    J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA; Cahn WY; Du Vigneaud V
    J Med Chem; 1972 Jan; 15(1):11-2. PubMed ID: 5061981
    [No Abstract]   [Full Text] [Related]  

  • 28. Glutamine isomers of oxytocin and deamino-oxytocin: synthesis and pharmacological properties of [4-N4-methyl-L-asparagine]-oxytocin and [1-beta-mercaptopropionic acid, 4-N4-methyl-L-asparagine]-oxytocin.
    Havran RT; Schwartz IL; Walter R
    Mol Pharmacol; 1969 Jan; 5(1):83-9. PubMed ID: 5373890
    [No Abstract]   [Full Text] [Related]  

  • 29. Solid-phase synthesis and biological activity of the parallel dimer of deamino-oxytocin.
    Munson MC; Lebl M; Slaninová J; Barany G
    Pept Res; 1993; 6(3):155-9. PubMed ID: 8318747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and some pharmacological properties of two new antagonists of oxytocin.
    Rekowski P; Melin P; Lammek B
    Pol J Pharmacol Pharm; 1987; 39(3):303-7. PubMed ID: 3438212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of high-performance liquid chromatography in the quality control of oxytocin, vasopressin and synthetic analogues.
    Maxl F; Siehr W
    J Pharm Biomed Anal; 1989; 7(2):211-6. PubMed ID: 2488622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation.
    Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ
    Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synthesis of (1-deamino,4-L-leucine)-oxytocin and (1-deamino,4-L-isoleucine)-oxytocin and some of their pharmacological properties.
    Takashima H; Hruby VJ; Du Vigneaud V
    J Am Chem Soc; 1970 Feb; 92(3):677-80. PubMed ID: 5460748
    [No Abstract]   [Full Text] [Related]  

  • 37. The synthesis and some pharmacological activities of[4-L-norvaline]-oxytocin and [4-L-norleucine]-oxytocin and their deamino analogs.
    Flouret G; Du Vigneaud V
    J Med Chem; 1969 Nov; 12(6):1035-8. PubMed ID: 5389145
    [No Abstract]   [Full Text] [Related]  

  • 38. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.
    Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY
    J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
    Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
    J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofunctional evaluation of two hydrogen bonds stabilizing the beta-turn in the acyclic component of oxytocin.
    Roy U; Gazis D; Schwartz IL; Roy J
    Int J Pept Protein Res; 1983 Oct; 22(4):398-403. PubMed ID: 6654586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.